Oncolog-Hematolog.ro
Medichub Media Β· Romania Β· Est. 2015
Aims & Scope⦠Inferred from recent articles
Oncolog-Hematolog.ro publishes research on various aspects of oncology and hematology. The journal covers topics such as the integration of palliative care in cancer treatment, the management of specific hematological malignancies like diffuse large B-cell lymphoma and acute monocytic leukemia, and the diagnosis and treatment of solid tumors including renal cancer, prostate cancer, and breast cancer. It also explores novel therapeutic approaches like CRISPR-Cas9 technology and immune checkpoint inhibitors, as well as the impact of cancer and its treatments on patient quality of life and adverse events.
AI-summarised from recent articles Β· verify on publisher page β
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex Β· Each yearβs green bar = citations earned by that yearβs papers, counted to date β so recent years look lower simply because their papers havenβt had time to be cited yet.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Oncolog-Hematolog.ro
Is Oncolog-Hematolog.ro a predatory journal?
PubScope has no integrity flags on record for Oncolog-Hematolog.ro: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee β always confirm fit and policies before submitting.
What is the impact factor of Oncolog-Hematolog.ro?
Oncolog-Hematolog.ro is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its open 2-year mean citedness is 0.02.
Is Oncolog-Hematolog.ro indexed in Scopus and Web of Science?
Oncolog-Hematolog.ro is indexed in DOAJ.
You May Also Like
See all βData updated: 2026-05-26 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref